Physician profile

Khoi Duc Than

Neurological Surgery · Durham, NC

NPI 1326269671

$192,151.24

in general payments reported to CMS, 2019-2025

39 companies · $16K in 2025

The $16K reported for 2025 was more than what 88% of Neurological Surgery providers received nationally (typical 2025 total: $604).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$15,016.25
Food and Beverage$8,826.27
Travel and Lodging$7,442.24

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Bioventus LLC $56,833.63 2019-2025 Sonastar, Other
Si-Bone, INC. $19,710.20 2021-2025
Globus Medical, INC. $17,898.94 2019-2025 Excelsius Gps, Reline, Excelsius3d Imaging System
Nuvasive, INC. $15,115.72 2019-2023 Xlif, Simplify Cervical Artificial Disc, Pulse
Medical Device Business Services, INC. $14,623.45 2019-2025 Expedium, Viper, Symphony
Djo, LLC $10,989.33 2019-2023 Cmf
Depuy Synthes Sales INC. $9,387.27 2019-2025 Velys, Teligen, Conduit
Lifenet Health $7,045.54 2019-2025 Allograft Vmis Delivery System, Pliafx Flo
Integrity Implants INC. $6,746.69 2020-2022
Alphatec Spine, INC $6,506.07 2019-2025 Other - Miscellaneous
Depuy Synthes Products, INC. $6,229.68 2021-2022
Medtronic, INC. $4,282.50 2021-2025 Stealthstation S8 Platform, Mazor X System, Anteralign Spinal System With Titan Nanolock Surface Technology
Carlsmed, INC. $3,632.07 2022-2025 Aprevo
Innovasis INC $2,756.87 2019
Medtronic USA, INC. $2,133.51 2019-2020
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Cerapedics INC. $1,455.68 2021-2024 I-Factor Peptide Enhanced Bone Graft
Spineology INC. $1,370.23 2019-2024 Optimesh Expandable Interbody Fusion System
Ctl Medical Corporation $1,259.31 2019
Brainlab, INC. $858.97 2019
Biogen, INC. $800.00 2020
Spineart USA INC $590.00 2024
Stryker Corporation $481.62 2019-2021
Zimmer Biomet Holdings, INC. $464.12 2019
Providence Medical Technology, INC. $136.69 2023-2025
Adcura, INC. $132.34 2023
Osteocentric Technologies, INC. $129.88 2025 Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St
Synaptive Medical INC. $119.80 2019
Seaspine Orthopedics Corporation $107.03 2021
Tricoast Surgical Solutions LLC $88.37 2024
Viseon, INC. $70.00 2023 Maxview System - Lateral Set
Medicrea USA, Corp. $60.28 2019
Arteriocyte Medical Systems, INC. $30.80 2023 Magellan
Kuros Biosciences USA, INC $30.01 2024 Magnetos
Intrinsic Therapeutics $25.02 2023 Barricaid Acd (Annular Closure Device)
Biocomposites INC $22.71 2023 Stimulan
Orthocell LTD $19.55 2025 Remplir
Choice Spine, LLC $7.36 2021

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Khoi Duc Than

$192,151.24

in general payments reported 2019-2025

Years
2019-2025
Top company
Bioventus LLC
Context
The $16K reported for 2025 was more than what 88% of Neurological Surgery providers received nationally (typical 2025 total: $604).

https://glasscript.com/doctor/105975/khoi-duc-than

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.